BALTIMORE The Homeopathic Pharmacopoeia Convention of the United States last week awarded John “Jack” Borneman, III, its Wyrth Post Baker Lifetime Achievement Award for his more than 35 years of service to the homeopathy industry.
Borneman has spent his lifetime committed to the development and regulation of homeopathic medicine within the United States as the third of four generations of “John Bornemans” who attended the Philadelphia College of Pharmacy. Upon graduation, Borneman joined the firm of John A. Borneman and Sons, Homeopathic Pharmacists, which was founded by his grandfather in 1907. In 1980, Borneman was a founding director of HPCUS, and in 1983, he was elected the second president of the organization. In the course of his 25 years as president, his leadership evolved HPCUS into a respected international body of scientists and experts. His work has led to the wide availability of standardized, high-quality medications to the general public. In Aug. 2008, Borneman assumed the role of HPCUS chairman of the board, where he continues to be a guiding force in a rapidly growing industry. He continues to lecture on homeopathy to both pharmacy and physician assistant students at University of the Sciences, and maintains a practice in community pharmacy and patient care at Treatment Options Pharmacy in King of Prussia, Pa.
The HPCUS also recognized Andy Bormeth and Edward Conway with its Awards of Merit for Service to Homeopathy. Bormeth, who passed away July 19, 2009, was recognized for his contributions to HPCUS, including extending accessibility to the modern HPUS by creating its online presence and utility. His award was accepted on his behalf by his wife of 20 years, Celinda Bormeth.
Conway contributes to HPCUS on an ongoing basis as its editorial and Web site content manager. He volunteers his time to extend Bormeth’s initial efforts to include news and other relevant information to interested parties at www.hpus.com.
The Homeopathic Pharmacopoeia Convention of the United States sets standards for quality and safety of homeopathic drugs in the United States by maintaining and regularly updating the Homeopathic Pharmacopoeia of the United States (HPUS). The HPUS is the official compendium within the meaning of the Federal Food, Drug and Cosmetic Act for listing of homeopathic drugs and is the technical basis for FDA regulation of the industry. The organization is composed of technical experts in the field of homeopathic medicine including: clinicians, pharmacists, biologists, chemists, botanists, toxicologists, and safety, legal and policy experts. HPCUS meets regularly to consider new drug monographs and technical standards.